The effect of homologous and heterologous carriers on the immunogenicity of the galactocerebroside hapten.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000941:Antigens; D002352:Carrier Proteins; D002554:Cerebrosides / Q000008:administration & dosage / Q000276:immunology*; D003168:Complement Fixation Tests; D005620:Freund's Adjuvant; D005690:Galactose / Q000008:administration & dosage / Q000276:immunology; D006241:Haptens / Q000008:administration & dosage / Q000276:immunology; D007109:Immunity; D007114:Immunization; D007274:Injections, Intraperitoneal; D008297:Male; D009169:Mycobacterium tuberculosis / Q000276:immunology; D010567:Pertussis Vaccine / Q000276:immunology; D051381:Rats; D011919:Rats, Inbred Strains; D012710:Serum Albumin, Bovine; D013601:T-Lymphocytes / Q000276:immunology
D000941:Antigens; D002352:Carrier Proteins; D002554:Cerebrosides; D006241:Haptens; D010567:Pertussis Vaccine; D012710:Serum Albumin, Bovine; D005620:Freund's Adjuvant; D005690:Galactose